Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease.
about
Untangling the Manganese-α-Synuclein WebIs Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative DiseasesMutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystoniaEnvironmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies.α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.Alpha-synuclein: relating metals to structure, function and inhibition.Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's diseaseLooking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism.Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases.Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.Imaging of neuronal tissues by x-ray diffraction and x-ray fluorescence microscopy: evaluation of contrast and biomarkers for neurodegenerative diseases.Occupational Metal Exposure and Parkinsonism.Molecular Role of Ca2+ and Hard Divalent Metal Cations on Accelerated Fibrillation and Interfibrillar Aggregation of α-Synuclein.Subchronic, Low-Level Intraperitoneal Injections of Manganese (IV) Oxide and Manganese (II) Chloride Affect Rat Brain Neurochemistry.Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.Ascorbate Oxidation by Cu(Amyloid-β) Complexes: Determination of the Intrinsic Rate as a Function of Alterations in the Peptide Sequence Revealing Key Residues for Reactive Oxygen Species Production.Parkinsonism in Inherited Metabolic Disorders: Key Considerations and Major FeaturesBioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disorders
P2860
Q26740340-0CA8E6AB-1EBF-4C8E-8C79-249AB934EF93Q26765787-BCAA1341-EDC2-49C9-BD14-B9E6E0646AA3Q27316540-C027C7AE-0C0F-4924-83C2-74BF33C81F02Q37369400-02595C9E-8B38-485C-AB8F-875B8210AB8FQ37737068-B50ABE16-719D-4290-B4A3-3196429DC6F4Q38669019-7136ADAA-05B1-42AE-8265-693C5036FDE5Q38728563-5AE4A9A5-59FC-4C27-A647-4851D8133595Q38915163-695B9A32-E4C2-43D3-836F-95ACAD38E7EEQ38921067-A707BE39-A567-4662-9C36-1C1E9000435AQ39043644-B4A85F93-8AA1-453C-9F8D-6398E321345CQ39205712-7FBB6272-5A18-4971-8C9D-94BA083A292AQ39297100-99C49ACF-A1FF-48F0-A11D-188BBA718270Q39314484-C95D3304-291E-4AD2-882B-8365D20D4F51Q42510777-8B6CB616-549F-4BD6-B5F6-6FDD5A01BE93Q42639638-33640240-16B4-4161-82D0-5CD6738A429BQ46309593-B2526A86-7C2F-4889-8C63-DCDEF87C7B32Q48138690-7625207B-6371-4082-BA36-BE2BB25CEAF7Q51025658-45C6C173-A288-493F-89D3-EF62432C308BQ52332617-468650EB-4BA8-4213-9B16-681AF203D0B8Q52333665-C230D2F9-D73E-4CA0-9CB6-EAE822832722Q58122613-29B6E659-42AE-4E6A-99A6-D4E112245402Q58805374-72846B95-8F29-4FE8-9140-F4B396734A15
P2860
Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Insights on the interaction of ...... iology of Parkinson's disease.
@en
type
label
Insights on the interaction of ...... iology of Parkinson's disease.
@en
prefLabel
Insights on the interaction of ...... iology of Parkinson's disease.
@en
P2860
P356
P1433
P1476
Insights on the interaction of ...... iology of Parkinson's disease.
@en
P2093
Eleonora Carboni
Paul Lingor
P2860
P304
P356
10.1039/C4MT00339J
P577
2015-03-01T00:00:00Z